INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$0

$0

Total Sells (Filtered)

$11.2M

$11,187,469

View Raw Line-Items

Live Feed: 2026-04-02

Timeline

Side

Size

All $1M+ $5M+ $10M+

Role

Ticker Search

Clear Clear Filters

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
ADPT S Adaptive Biotechnologies Corp BENZENO SHARON • Officer • Chief Commercial Ofc Imm Med Sell to CoverΔOwn -18.8% 2026-03-11 $831,067 View Form 4 →
ADPT	Adaptive Biotechnologies Corp	BENZENO SHARON Officer • Chief Commercial Ofc Imm Med Sell to CoverΔOwn -18.8%	2026-03-11	$831,067	S	Form 4
ADPT S Adaptive Biotechnologies Corp BENZENO SHARON • Officer • Chief Commercial Ofc Imm Med 10b5-1 Sell 2025-12-04 $212,377 View Form 4 →
ADPT	Adaptive Biotechnologies Corp	BENZENO SHARON Officer • Chief Commercial Ofc Imm Med 10b5-1 Sell	2025-12-04	$212,377	S	Form 4
ADPT S Adaptive Biotechnologies Corp BENZENO SHARON • Officer • Chief Commercial Ofc Imm Med 10b5-1 SellΔOwn -51.0% 2025-11-21 $5,216,346Whale View Form 4 →
ADPT	Adaptive Biotechnologies Corp	BENZENO SHARON Officer • Chief Commercial Ofc Imm Med 10b5-1 SellΔOwn -51.0%	2025-11-21	$5,216,346Whale	S	Form 4
ADPT S Adaptive Biotechnologies Corp BENZENO SHARON • Officer • Chief Commercial Ofc Imm Med 10b5-1 SellΔOwn -50.1% 2025-11-20 $4,927,680Large View Form 4 →
ADPT	Adaptive Biotechnologies Corp	BENZENO SHARON Officer • Chief Commercial Ofc Imm Med 10b5-1 SellΔOwn -50.1%	2025-11-20	$4,927,680Large	S	Form 4